Business ❯ Pharmaceuticals

Biopharmaceuticals

Drug Development Manufacturing Product Development Biosimilars Acquisitions Medical Devices Oncology Regulatory Affairs Therapeutics Cell-based Therapies Merck KGaA Neurology Research and Development Anticoagulation Therapy Clinical Trials

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

The signed deal would place an activin‑pathway therapy with phase 1 data into GSK’s RI&I pipeline pending U.S. and Canadian clearance.

AbbVie to Invest $380 Million in Two North Chicago API Plants

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

Telix Faces Securities Class Action Over Prostate Cancer Disclosures and Supply Chain Claims

Telix Hit With Securities Class Action Over Prostate-Drug Claims and Supply Chain Assurances